Ein von ISO 9001, 14001, 45001 zertifiziertes Unternehmen sales@bldpharm.com
Währung :
Sprache : Deutsch |
Standort :
Standort
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |
          Startseite/ Chemistry/ Asymmetric Synthesis/ Chiral Building Blocks/(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl (2-(dimethylamino)ethyl)carbamate

          (3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl (2-(dimethylamino)ethyl)carbamate

          CAS NO.: 137056-72-5  
            Größe Preis Verkaufsrabatt Rabatt Lager-CN Lager-US Lager-IND Lager-EU Menge
            How to Order

            The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

            How to Order

            QUALITÄTSKONTROLLE Batch NO.:

            166023-21-8
            BD00798730 166023-21-8 Free-Salt

            PRODUKT INFORMATION

            Produkt Name : (3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl (2-(dimethylamino)ethyl)carbamate
            CAS Nr. : 137056-72-5 Molekulargewicht : 500.80
            MDL Nr. : MFCD30536817 Feinheit/Spezifikation :
            Molekularformel : C32H56N2O2 Lagerung : Sealed in dry,Store in freezer, under -20°C
            Siedepunkt : No data available
            GHS Pictogram :
            Signal Word : Warning Precautionary Statements : P264-P270-P273-P301+P312-P330-P501
            UN# : - Class : -
            Hazard Statements : H302-H413 Packing Group : -

            ZUSAMMENHÄNGENDE PRODUKTE

            HISTORISCHE AUFZEICHNUNGEN